Erythromelalgia treatment gains regulatory support following EMA decision
PASO DOBLE sub‑analysis indicates metabolic differences between 2‑drug and 3‑drug HIV regimens
Childhood vaccination targets for general practices in England will be overhauled to provide extra financial support to practices […]
The theme for International Women’s Day 2026 is rights, justice, and action for all women and girls. By […]
AbstractOver the past 15 years, psychedelic treatments have garnered substantial clinical interest, with psilocybin and 3,4-methylenedioxymethamphetamine (MDMA) advancing […]
Updated Date: Mon, 16 Feb 2026 00:00:00 EST
What happened?The science funding body UK Research and Innovation (UKRI) is made up of seven research councils, including […]
As demand for glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy), and GLP-1 and glucose dependent […]
QUASAR long‑term extension results highlight durable clinical and endoscopic outcomes
MHRA authorises medicine for patients aged 12 and over with repeated flare‑ups